Published in J Allergy Clin Immunol on January 01, 1984
Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils. J Clin Invest (1986) 2.90
The accumulation of 111In-eosinophils induced by inflammatory mediators, in vivo. Immunology (1991) 1.55
Eosinophils as effector cells in immunity and hypersensitivity disorders. Clin Exp Immunol (1985) 1.12
Nutritional status according to sensitized food allergens in children with atopic dermatitis. Allergy Asthma Immunol Res (2010) 0.92
The idiopathic hypereosinophilic syndrome. Arch Dis Child (1987) 0.91
Immune responses of CBA/J mice to graded infections with Toxocara canis. Infect Immun (1985) 0.87
The effects of eosinophil activating factor on IgG-dependent sulphidopeptide leukotriene generation by human eosinophils. Clin Exp Immunol (1986) 0.83
Allergy-important advances in clinical medicine: eosinophils. West J Med (1984) 0.75
Evaluation of the common conditions associated with eosinophilia. J Clin Pathol (1985) 0.75
Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system. J Immunol (1982) 5.44
Specific cellular immune unresponsiveness in human filariasis. Immunology (1977) 2.23
Human eosinophils express transforming growth factor alpha. J Exp Med (1990) 2.04
The role of encapsulation and host age in the clearance of Haemophilus influenzae bacteremia. J Infect Dis (1977) 2.01
Interleukin 5 and phenotypically altered eosinophils in the blood of patients with the idiopathic hypereosinophilic syndrome. J Exp Med (1989) 1.97
Generation and metabolism of 5-lipoxygenase pathway leukotrienes by human eosinophils: predominant production of leukotriene C4. Proc Natl Acad Sci U S A (1983) 1.91
Bronchoconstrictor effects of leukotriene C in humans. Science (1982) 1.91
Lymph node trafficking and antigen presentation by endobronchial eosinophils. J Clin Invest (2000) 1.85
Mechanisms of eosinophil recruitment. Am J Respir Cell Mol Biol (1993) 1.65
Role of immunity in the clearance of bacteremia due to Haemophilus influenzae. J Infect Dis (1978) 1.65
Strongyloidiasis and other intestinal nematode infections. Infect Dis Clin North Am (1993) 1.63
Mature human eosinophils have the capacity to express HLA-DR. Proc Natl Acad Sci U S A (1989) 1.62
CD4-mediated stimulation of human eosinophils: lymphocyte chemoattractant factor and other CD4-binding ligands elicit eosinophil migration. J Exp Med (1991) 1.58
IL-4 directly modulates function of a model human intestinal epithelium. J Immunol (1994) 1.53
Characterization of a receptor for C5a anaphylatoxin on human eosinophils. J Biol Chem (1989) 1.49
Expression of vascular endothelial growth factor by human eosinophils: upregulation by granulocyte macrophage colony-stimulating factor and interleukin-5. Am J Respir Cell Mol Biol (1997) 1.45
The regulation of human eosinophil function by endogenous mono-hydroxy-eicosatetraenoic acids (HETEs). J Immunol (1980) 1.36
Lipoxin recognition sites. Specific binding of labeled lipoxin A4 with human neutrophils. J Biol Chem (1992) 1.35
Cutting edge: eotaxin elicits rapid vesicular transport-mediated release of preformed IL-4 from human eosinophils. J Immunol (2001) 1.33
Eosinophil lipid bodies: specific, inducible intracellular sites for enhanced eicosanoid formation. J Exp Med (1997) 1.32
Phosphatidylinositide 3-kinase localizes to cytoplasmic lipid bodies in human polymorphonuclear leukocytes and other myeloid-derived cells. Blood (2000) 1.31
Release of C8 binding protein (C8bp) from the cell membrane by phosphatidylinositol-specific phospholipase C. Blood (1988) 1.30
Identification of human eosinophil lysophospholipase as the constituent of Charcot-Leyden crystals. Proc Natl Acad Sci U S A (1980) 1.30
Co-compartmentalization of MAP kinases and cytosolic phospholipase A2 at cytoplasmic arachidonate-rich lipid bodies. Am J Pathol (1998) 1.30
Immunoregulatory roles of eosinophils: a new look at a familiar cell. Clin Exp Allergy (2008) 1.26
Human eosinophils express functional interleukin 2 receptors. J Clin Invest (1991) 1.26
Leukocyte lipid body formation and eicosanoid generation: cyclooxygenase-independent inhibition by aspirin. Proc Natl Acad Sci U S A (1996) 1.26
The effect of human eosinophil granule major basic protein on airway responsiveness in the rat in vivo. A comparison with polycations. Am Rev Respir Dis (1993) 1.25
Eosinophils from patients with blood eosinophilia express transforming growth factor beta 1. Blood (1991) 1.24
Human eosinophils can express the cytokines tumor necrosis factor-alpha and macrophage inflammatory protein-1 alpha. J Clin Invest (1993) 1.23
Extranuclear lipid bodies, elicited by CCR3-mediated signaling pathways, are the sites of chemokine-enhanced leukotriene C4 production in eosinophils and basophils. J Biol Chem (2001) 1.21
Antiparasitic drugs. N Engl J Med (1996) 1.20
Human eosinophils elaborate the lymphocyte chemoattractants. IL-16 (lymphocyte chemoattractant factor) and RANTES. J Immunol (1996) 1.20
Endemic filariasis on a Pacific Island. II. Immunologic aspects: immunoglobulin, complement, and specific antifilarial IgG, IgM, and IgE antibodies. Am J Trop Med Hyg (1982) 1.19
Phosphatidylinositol-specific phospholipase C, a possible virulence factor of Staphylococcus aureus. J Clin Microbiol (1989) 1.17
Human eosinophils express CD4 protein and bind human immunodeficiency virus 1 gp120. J Exp Med (1989) 1.16
Familial predisposition to filarial infection--not linked to HLA-A or-B locus specificities. Acta Trop (1981) 1.15
The regulatory and effector roles of eosinophils. Adv Immunol (1979) 1.14
Ultrastructural immunogold localization of tumor necrosis factor-alpha to the matrix compartment of eosinophil secondary granules in patients with idiopathic hypereosinophilic syndrome. J Histochem Cytochem (1993) 1.14
Bancroftian filariasis and ivermectin. N Engl J Med (1990) 1.11
Fluorescent staining for leukocyte chemotaxis. Eosinophil-specific fluorescence with aniline blue. J Immunol Methods (1988) 1.11
IL-4-dependent regulation of TGF-alpha and TGF-beta1 expression in human eosinophils. J Immunol (1998) 1.10
IL-16 inhibition of CD3-dependent lymphocyte activation and proliferation. J Immunol (1996) 1.10
Ultrastructural immunogold localization of prostaglandin endoperoxide synthase (cyclooxygenase) to non-membrane-bound cytoplasmic lipid bodies in human lung mast cells, alveolar macrophages, type II pneumocytes, and neutrophils. J Histochem Cytochem (1992) 1.10
Prostaglandin endoperoxide synthase (cyclooxygenase): ultrastructural localization to nonmembrane-bound cytoplasmic lipid bodies in human eosinophils and 3T3 fibroblasts. Int Arch Allergy Immunol (1994) 1.09
The cells of the allergic response: mast cells, basophils, and eosinophils. JAMA (1997) 1.09
CD40 expression by human peripheral blood eosinophils. J Clin Invest (1996) 1.07
Mechanisms of platelet-activating factor-induced lipid body formation: requisite roles for 5-lipoxygenase and de novo protein synthesis in the compartmentalization of neutrophil lipids. J Exp Med (1996) 1.07
The human eosinophil: roles in host defense and tissue injury. Am J Pathol (1980) 1.07
Arachidonic acid incorporation by cytoplasmic lipid bodies of human eosinophils. Blood (1985) 1.06
EliCell: a gel-phase dual antibody capture and detection assay to measure cytokine release from eosinophils. J Immunol Methods (2000) 1.06
Ultrastructural immunogold localization of subcellular sites of TNF-alpha in colonic Crohn's disease. J Leukoc Biol (1995) 1.04
Eotaxins. Contributing to the diversity of eosinophil recruitment and activation. Am J Respir Cell Mol Biol (2001) 1.02
Eosinophil ablation and tumor development. Oral Oncol (1999) 1.02
The spectrum of Bacillus bacteremias in heroin addicts. Arch Intern Med (1979) 1.02
Fever and headache in a splenectomized woman. Rev Infect Dis (1989) 1.02
Release of prostaglandin E2 by microfilariae of Wuchereria bancrofti and Brugia malayi. Am J Trop Med Hyg (1992) 1.01
Intravascular filarial parasites elaborate cyclooxygenase-derived eicosanoids. J Exp Med (1990) 1.01
Airway eosinophils and lymphocytes in asthma. Birds of a feather? Am Rev Respir Dis (1992) 0.99
Lack of TGF-alpha and TGF-beta 1 synthesis by human eosinophils in chronic oral ulcers. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1996) 0.99
Ultrastructural localization of Charcot-Leyden crystal protein (lysophospholipase) and peroxidase in macrophages, eosinophils, and extracellular matrix of the skin in the hypereosinophilic syndrome. Lab Invest (1990) 0.99
Worm burden and host responsiveness in Wuchereria bancrofti infection: use of antigen detection to refine earlier assessments from the South Pacific. Am J Trop Med Hyg (2001) 0.97
Cell-mediated immunity in experimental filariasis: lymphocyte reactivity to filarial stage-specific antigens and to B- and T-cell mitogens during acute and chronic infection. Cell Immunol (1978) 0.96
Production of transforming growth factor alpha by hamster eosinophils. Am J Pathol (1990) 0.96
Arachidonic acid metabolism in filarial parasites. Exp Parasitol (1990) 0.95
Iodopyracet transport by isolated perfused flounder proximal renal tubules. Am J Physiol (1969) 0.95
Imported Fasciola hepatica infection in the United States and treatment with triclabendazole. Clin Infect Dis (2001) 0.94
Incorporation of arachidonic acid by microfilariae of Brugia malayi. J Infect Dis (1985) 0.94
Eosinophilia and elevated serum levels of eosinophil major basic protein and Charcot-Leyden crystal protein (lysophospholipase) after treatment of patients with Bancroft's filariasis. J Immunol (1981) 0.94
Tourism-acquired Mansonella ozzardi microfilaremia in a regular blood donor. JAMA (1978) 0.93
Biochemical characterization of human eosinophil Charcot-Leyden crystal protein (lysophospholipase). J Biol Chem (1984) 0.92
Heterogeneity of leukotriene C4 production by eosinophils from asthmatic and from normal subjects. Am Rev Respir Dis (1988) 0.91
Depletion of eosinophil infiltration by anti-IL-5 monoclonal antibody (TRFK-5) accelerates open skin wound epithelial closure. Am J Pathol (1997) 0.90
Pathways for eosinophil lipid body induction: differing signal transduction in cells from normal and hypereosinophilic subjects. J Leukoc Biol (1998) 0.90
Ultrastructural localization of prostaglandin endoperoxide synthase (cyclooxygenase) to isolated, purified fractions of guinea pig peritoneal macrophage and line 10 hepatocarcinoma cell lipid bodies. Int Arch Allergy Immunol (1993) 0.88
Intravascular filarial parasites inhibit platelet aggregation. Role of parasite-derived prostanoids. J Clin Invest (1992) 0.88
Expression of transforming growth factors-alpha and beta 1 messenger RNA and product by eosinophils in nasal polyps. J Allergy Clin Immunol (1994) 0.88
Human eosinophil stimulation promoter lymphokine: production by antigen stimulated lymphocytes and assay with a new electro-optical technique. Cell Immunol (1978) 0.87
Comparative bronchoconstrictor effects of histamine, leukotriene C, and leukotriene D in normal human volunteers. Trans Assoc Am Physicians (1982) 0.87
Brugia malayi: microfilarial polyunsaturated fatty acid composition and synthesis. Exp Parasitol (1989) 0.86
RNA is closely associated with human mast cell lipid bodies. Histol Histopathol (2003) 0.86
Sequential alterations in the human eosinophil content of arylsulfatase B during therapy of Bancroftian filariasis. Clin Immunol Immunopathol (1981) 0.86
Hemolytically inactive C5b67 complex: an agonist of polymorphonuclear leukocytes. Blood (1995) 0.86
Molecular cloning and characterization of human eosinophil Charcot-Leyden crystal protein (lysophospholipase). Similarities to IgE binding proteins and the S-type animal lectin superfamily. J Immunol (1993) 0.86
Salivary EGF regulates eosinophil-derived TGF-alpha expression in hamster oral wounds. Am J Physiol (1996) 0.86
Endemic filariasis on a Pacific island. I. Clinical, epidemiologic, and parasitologic aspects. Am J Trop Med Hyg (1982) 0.86
Activated eosinophils evoke chloride secretion in model intestinal epithelia primarily via regulated release of 5'-AMP. J Immunol (1993) 0.86
Immediate and delayed hypersensitivity skin test responses to the Dirofilaria immitis filarial skin test (Sawada) antigen in Wuchereria bancrofti filariasis. Am J Trop Med Hyg (1980) 0.85
The idiopathic hypereosinophilic syndrome. Arch Dermatol (1996) 0.85
Failure of diethylcarbamazine as a provocative test in subperiodic Wuchereria bancrofti filariasis. Trans R Soc Trop Med Hyg (1978) 0.85
Travel vaccines and elderly persons: review of vaccines available in the United States. Clin Infect Dis (2001) 0.85
Eosinophilia and helminthic infections. Baillieres Best Pract Res Clin Haematol (2000) 0.84
Eosinophilia following treatment of patients with schistosomiasis mansoni and Bancroft's filariasis. J Infect Dis (1979) 0.84
Induction of endothelial cell cytoplasmic lipid bodies during hypoxia. Am J Physiol Heart Circ Physiol (2001) 0.84
The consequences of not having eosinophils. Allergy (2013) 0.83
HLA histocompatibility antigens in a Polynesian population -- Cook islanders of Mauke. Tissue Antigens (1979) 0.83
Rapid uptake and esterification of arachidonic acid and other fatty acids by microfilariae of Brugia malayi. Mol Biochem Parasitol (1987) 0.83
Hypereosinophilia and recurrent angioneurotic edema in a 2 1/2-year-old girl. Am J Dis Child (1986) 0.83
Human eosinophil lysophospholipase: the sole protein component of Charcot-Leyden crystals. J Immunol (1982) 0.82